|
Volumn 85, Issue 10, 2001, Pages 1585-1591
|
Lycobetaine acts as a selective topoisomerase IIβ poison and inhibits the growth of human tumour cells
b a d a a b c,d a a |
Author keywords
Cleavable complex; Clonogenic assay; Gastric carcinoma; Lycobetaine; Topoisomerase II ; Ungeremine
|
Indexed keywords
GYRASE INHIBITOR;
LYCOBETAINE;
PHENANTHRIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER INHIBITION;
CONTROLLED STUDY;
DNA CLEAVAGE;
DRUG STRUCTURE;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
IC 50;
INHIBITION KINETICS;
LEUKEMIA CELL LINE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DEPLETION;
TUMOR XENOGRAFT;
ALKALOIDS;
AMARYLLIDACEAE ALKALOIDS;
ANIMALS;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BLOTTING, WESTERN;
CELL CYCLE;
CELL DIVISION;
COMET ASSAY;
DNA;
DNA DAMAGE;
DNA TOPOISOMERASES, TYPE II;
DNA TOPOISOMERASES, TYPE II, EUKARYOTIC;
DNA-BINDING PROTEINS;
ENZYME INHIBITORS;
HL-60 CELLS;
HUMANS;
INDOLIZINES;
MICE;
MICE, NUDE;
NEOPLASMS, EXPERIMENTAL;
TUMOR CELLS, CULTURED;
TUMOR STEM CELL ASSAY;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0035900807
PISSN: 00070920
EISSN: None
Source Type: Journal
DOI: 10.1054/bjoc.2001.2142 Document Type: Article |
Times cited : (48)
|
References (27)
|